Lecture Details - Overview

View all Online CME

Continuing Education Information

Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Rapid Reviews in Oncology: Emerging Options in the Treatment of Breast Cancer June 2008

Release Date: July 2, 2008| Expiration Date: July 2, 2009
Jun 25-Jul 2, 2008, Dallas, TX

Lecture Overview

Rapid Reviews in Oncology: Emerging Options in the Treatment of Breast Cancer is a series of CME-designated conferences that focus on cutting-edge clinical updates on the management of patients with breast cancer. The series, which is intended for practicing community oncologists, includes didactic lectures followed by an interactive discussion of cases and clinical questions with the faculty of nationally recognized thought leaders.

These conferences are nationally broadcast programs designed to simultaneously update oncologists on current and late-breaking data delivered via satellite to an audience of oncologists through a network of private dining rooms located in restaurants throughout the country. The meetings will feature interactive participation with each site, including live questions beamed in from locations throughout the network.

This educational program is directed toward medical oncologists, including fellows in training, involved in the treatment of patients with breast cancers. Oncology nurses, oncology physician assistants, and pharmacists who are interested in the treatment of cancer are also invited to attend.

Upon completion of this educational activity, you should be able to:

  • Evaluate the activity of epothilones, alternative taxane formulations, and other novel microtubule-targeting agents, alone or in combination regimens, in patients with relapsed/refractory metastatic breast cancer
  • Assess the efficacy and safety of antiangiogenic therapies with taxanes in newly diagnosed metastatic breast cancer
  • Discuss antiangiogenic agents undergoing clinical investigation in metastatic breast cancer
  • Evaluate current data on the efficacy and safety of nonanthracycline regimens in the adjuvant treatment of breast cancer

Instructions for Participation

  1. Read the following information before beginning the educational activity.
  2. View and study all Flash video presentations.
  3. Complete the CME test.
  4. Answer the evaluation questions.
  5. After successful completion of the CME test and evaluation,
    you will receive your certificate of credit online.
  • CME credit will be granted for online participation only.
View the Activity
You will be asked to login
or create an account.

Educational Grants

An educational grant for this activity was provided by:


  1. Genentech BioOncology
  2. Bristol-Myers Squibb